IL133386A0 - Benzpyrido cycloheptane compounds useful for inhibition of a farnesyl protein transferase - Google Patents

Benzpyrido cycloheptane compounds useful for inhibition of a farnesyl protein transferase

Info

Publication number
IL133386A0
IL133386A0 IL13338698A IL13338698A IL133386A0 IL 133386 A0 IL133386 A0 IL 133386A0 IL 13338698 A IL13338698 A IL 13338698A IL 13338698 A IL13338698 A IL 13338698A IL 133386 A0 IL133386 A0 IL 133386A0
Authority
IL
Israel
Prior art keywords
benzpyrido
inhibition
compounds useful
protein transferase
farnesyl protein
Prior art date
Application number
IL13338698A
Other languages
English (en)
Original Assignee
Schering Corp
Pharmacopeia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp, Pharmacopeia Inc filed Critical Schering Corp
Publication of IL133386A0 publication Critical patent/IL133386A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13338698A 1997-06-17 1998-06-15 Benzpyrido cycloheptane compounds useful for inhibition of a farnesyl protein transferase IL133386A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87774197A 1997-06-17 1997-06-17
PCT/US1998/011495 WO1998057960A1 (en) 1997-06-17 1998-06-15 Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase

Publications (1)

Publication Number Publication Date
IL133386A0 true IL133386A0 (en) 2001-04-30

Family

ID=25370618

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13338698A IL133386A0 (en) 1997-06-17 1998-06-15 Benzpyrido cycloheptane compounds useful for inhibition of a farnesyl protein transferase
IL133386A IL133386A (en) 1997-06-17 1999-12-08 Compounds of benzapirido cycloheptane useful for inhibiting francil protein transferase

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL133386A IL133386A (en) 1997-06-17 1999-12-08 Compounds of benzapirido cycloheptane useful for inhibiting francil protein transferase

Country Status (18)

Country Link
EP (1) EP0989983B1 (https=)
JP (1) JP2002504144A (https=)
KR (1) KR100640672B1 (https=)
CN (1) CN1266433A (https=)
AR (1) AR012991A1 (https=)
AT (1) ATE273299T1 (https=)
AU (1) AU753658B2 (https=)
CA (1) CA2293714C (https=)
DE (1) DE69825589T2 (https=)
ES (1) ES2224408T3 (https=)
HU (1) HUP0003138A3 (https=)
IL (2) IL133386A0 (https=)
MY (1) MY143570A (https=)
NZ (1) NZ501376A (https=)
PE (1) PE104798A1 (https=)
TW (1) TW587935B (https=)
WO (1) WO1998057960A1 (https=)
ZA (1) ZA985203B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6362188B1 (en) 1998-12-18 2002-03-26 Schering Corporation Farnesyl protein transferase inhibitors
HUP0202152A2 (en) * 1998-12-18 2002-10-28 Schering Corp Tricyclyc farnesyl protein transferase inhibitors
US6800636B2 (en) 1998-12-18 2004-10-05 Schering Corporation Farnesyl protein transferase inhibitors
TR200101754T2 (tr) * 1998-12-18 2002-05-21 Schering Corporation Farnezil protein transferaz inhibitörleri
US6372747B1 (en) 1998-12-18 2002-04-16 Schering Corporation Farnesyl protein transferase inhibitors
US6432959B1 (en) * 1998-12-23 2002-08-13 Schering Corporation Inhibitors of farnesyl-protein transferase
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
WO2002056884A2 (en) * 2001-01-22 2002-07-25 Schering Corporation Treatment of malaria with farnesyl protein transferase inhibitors
WO2002080895A2 (en) * 2001-04-06 2002-10-17 Schering Corporation Treatment of malaria with farsenyl protein transferase inhibitors
EP1542993B1 (en) 2002-09-20 2012-12-19 Merck Serono SA Piperazine derivatives and methods of use
EP1838324A2 (en) 2004-12-13 2007-10-03 Schering Corporation Novel farnesyl protein transferase inhibitors and their use to treat cancer
EP1833481A1 (en) 2004-12-14 2007-09-19 Schering Corporation Farnesyl protein transferase inhibitors and methods for treating proliferative diseases
ES2798289T3 (es) * 2012-01-25 2020-12-10 Novartis Ag Compuestos heterocíclicos y métodos para su uso
EP3541375B1 (en) * 2016-11-18 2023-08-23 Merck Sharp & Dohme LLC Factor xiia inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
CA2174105C (en) * 1993-10-15 2002-02-12 W. Robert Bishop Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IL117797A0 (en) * 1995-04-07 1996-08-04 Pharmacopeia Inc Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5712280A (en) * 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
ES2224408T3 (es) 2005-03-01
CA2293714C (en) 2009-09-08
HUP0003138A3 (en) 2002-11-28
AR012991A1 (es) 2000-11-22
MY143570A (en) 2011-05-31
HUP0003138A2 (hu) 2001-06-28
KR100640672B1 (ko) 2006-11-02
DE69825589T2 (de) 2005-09-08
EP0989983A1 (en) 2000-04-05
EP0989983B1 (en) 2004-08-11
NZ501376A (en) 2002-03-28
CA2293714A1 (en) 1998-12-23
ATE273299T1 (de) 2004-08-15
DE69825589D1 (de) 2004-09-16
JP2002504144A (ja) 2002-02-05
CN1266433A (zh) 2000-09-13
PE104798A1 (es) 1999-11-06
KR20010013822A (ko) 2001-02-26
TW587935B (en) 2004-05-21
ZA985203B (en) 1999-01-05
AU8058098A (en) 1999-01-04
AU753658B2 (en) 2002-10-24
WO1998057960A1 (en) 1998-12-23
IL133386A (en) 2006-12-10

Similar Documents

Publication Publication Date Title
EP0994856A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
EP0696593A3 (en) Farnesyl protein transferase inhibitors
HUP9902016A3 (en) Inhibitors of farnesyl protein transferase
IL126833A0 (en) Inhibitors of protein farnesyl transferase
EP0918771A4 (en) THIADIOXOBENZODIAZEPINES FOR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS
CY2287B1 (en) Farnesyl transferase inhibiting 2-quinolone derivatives
IL123155A0 (en) 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
IL140720A0 (en) Farnesyl protein transferase inhibitors for treating arthropathies
EP1027042A4 (en) FARNESYL PROTEIN TRANSFERASE INHIBITORS
IL133386A0 (en) Benzpyrido cycloheptane compounds useful for inhibition of a farnesyl protein transferase
IL187181A0 (en) Polymorph of a pharmaceutical
IL143409A0 (en) Farnesyl protein transferase inhibitors
IL130453A0 (en) Farnesyl transferase inhibitors
ZA986623B (en) Hydantoin derivatives having an inhibitor activity for farnesyl transferase
HUP0202152A2 (en) Tricyclyc farnesyl protein transferase inhibitors
ZA985210B (en) Compounds for the inhibition of farnesyl protein transferase
IL133388A0 (en) Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
HUP0002186A3 (en) Compounds useful for inhibition of farnesyl protein transferase
HK1023114A (en) Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase
HK1023115A (en) Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
HK1019066A (en) Compounds useful for inhibition of farnesyl protein transferase
HK1018454A (en) Compounds useful for inhibition of farnesyl protein transferase
IL141626A0 (en) Farnesyl transferase inhibitors
HK1018264A (en) Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
ZA971621B (en) Inhibitors of farnesyl protein transferase

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed